American Journal of Psychiatry

• 

  Publication Venue For

  • The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders..  180:167-171. 2023
  • The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers..  180:41-49. 2023
  • Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults..  179:482-489. 2022
  • Making Therapy Widely Available: Clinical Research Triumph or Existential Catastrophe?.  179:79-82. 2022
  • Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study..  178:459-468. 2021
  • Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial..  176:957-965. 2019
  • Correlates of Future Violence in People Being Treated for Schizophrenia..  176:694-701. 2019
  • Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity..  176:358-366. 2019
  • Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts..  176:107-118. 2019
  • Improving Depression Outcome by Patient-Centered Medical Management..  175:1187-1198. 2018
  • Perspectives on the Management of Vascular Depression..  175:1169-1175. 2018
  • When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips..  175:1176-1184. 2018
  • Allan McLane Hamilton..  175:605-606. 2018
  • Can a Framework Be Established for the Safe Use of Ketamine?.  175:587-589. 2018
  • Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes..  175:665-673. 2018
  • Addressing Incomplete Psychiatric Histories in Adult ADHD: Response to Agnew-Blais and Arseneault..  175:482-483. 2018
  • The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller..  175:480-481. 2018
  • A Geriatrics Perspective on Dementia Prevention and Treatment..  175:199-201. 2018
  • Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25..  175:140-149. 2018
  • GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder..  174:1086-1093. 2017
  • Engaging Depressed Patients: An Essential Step in Optimizing Care..  174:506-507. 2017
  • A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness..  174:370-377. 2017
  • A Step Toward Optimizing Treatment Schedules for Continuation ECT: Response to Rasmussen..  174:397-398. 2017
  • Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA..  174:18-25. 2017
  • Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial..  173:1196-1204. 2016
  • A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept..  173:1140-1146. 2016
  • A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study..  173:1110-1118. 2016
  • Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study..  173:1101-1109. 2016
  • Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression..  173:481-490. 2016
  • Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression..  173:107-111. 2016
  • 2015 in Review..  172:1179-1181. 2015
  • Richard Dadd and the Fairy Feller's Master-Stroke..  172:1073-1074. 2015
  • A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder..  172:1014-1021. 2015
  • Isn't It About Time to Employ Measurement-Based Care in Practice?.  172:934-936. 2015
  • Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial..  172:743-750. 2015
  • Good news in the battle against military suicide..  172:406-407. 2015
  • Response to Gorelick..  172:395. 2015
  • Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age..  171:1214-1221. 2014
  • Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm..  171:1199-1205. 2014
  • Using the WHODAS 2.0 to assess functional disability associated with DSM-5 mental disorders..  171:818-820. 2014
  • Adult outcomes of childhood bullying victimization..  171:709-711. 2014
  • Screening for violence risk in military veterans: predictive validity of a brief clinical tool..  171:749-757. 2014
  • Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder..  171:668-674. 2014
  • Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome..  171:627-639. 2014
  • Response to Burns..  171:228-229. 2014
  • Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study..  171:91-101. 2014
  • Microvascular abnormality in schizophrenia as shown by retinal imaging..  170:1451-1459. 2013
  • The cost of assisted outpatient treatment: can it save states money?.  170:1423-1432. 2013
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study..  170:1275-1284. 2013
  • Preserved working memory and altered brain activation in persons at risk for psychosis..  170:1297-1307. 2013
  • Ketamine for treatment-resistant depression: ready or not for clinical use?.  170:1079-1081. 2013
  • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder..  170:1032-1040. 2013
  • Adapting smoking cessation treatment according to initial response to precessation nicotine patch..  170:860-867. 2013
  • Increase in work productivity of depressed individuals with improvement in depressive symptom severity..  170:633-641. 2013
  • Neurocognitive disorders in DSM-5..  170:585-587. 2013
  • Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies..  170:207-217. 2013
  • Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder..  170:173-179. 2013
  • Effect of a paraprofessional home-visiting intervention on American Indian teen mothers’ and infants’ behavioral risks: a randomized controlled trial..  170:83-93. 2013
  • Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium..  170:102-110. 2013
  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials..  169:1267-1274. 2012
  • Treatment course with antidepressant therapy in late-life depression..  169:1185-1193. 2012
  • Reduced amygdala response in youths with disruptive behavior disorders and psychopathic traits: decreased emotional response versus increased top-down attention to nonemotional features..  169:750-758. 2012
  • Differences in white matter fiber tract development present from 6 to 24 months in infants with autism..  169:589-600. 2012
  • Clues to the cognitive and perceptual origins of social isolation and psychosis in schizophrenia..  169:354-357. 2012
  • Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention?.  169:251-254. 2012
  • Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD..  169:167-177. 2012
  • Religion/spirituality and depression: what can we learn from empirical studies?.  169:10-12. 2012
  • A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)..  168:947-956. 2011
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD..  168:831-839. 2011
  • A systematic review of treatments for refractory depression in older people..  168:681-688. 2011
  • Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence..  168:675-679. 2011
  • Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study..  168:689-701. 2011
  • Effectiveness of switching from antipsychotic polypharmacy to monotherapy..  168:702-708. 2011
  • Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study..  168:593-602. 2011
  • Genome-wide association study of suicide attempts in mood disorder patients..  167:1499-1507. 2010
  • Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression..  167:1254-1263. 2010
  • Outcomes of early pubertal timing in young women: a prospective population-based study..  167:1218-1225. 2010
  • Correlates of anger and hostility in Iraq and Afghanistan war veterans..  167:1051-1058. 2010
  • Posttraumatic stress without trauma in children..  167:1059-1065. 2010
  • Treatment for PTSD related to childhood abuse: a randomized controlled trial..  167:915-924. 2010
  • Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder..  167:574-579. 2010
  • Combining antidepressant medications: a good idea?.  167:241-243. 2010
  • Beta-blockers and depression..  167:219. 2010
  • Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study..  167:160-169. 2010
  • Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder..  167:61-69. 2010
  • Drs. Blazer and Wu Reply..  167:106. 2010
  • The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up..  166:1141-1149. 2009
  • The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health..  166:1162-1169. 2009
  • Institutional rearing and psychiatric disorders in Romanian preschool children..  166:777-785. 2009
  • Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)..  166:675-682. 2009
  • Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report..  166:599-607. 2009
  • Reduced neural habituation in the amygdala and social impairments in autism spectrum disorders..  166:467-475. 2009
  • Assessment of safety and long-term outcomes of initial treatment with placebo in TADS..  166:337-344. 2009
  • Conflict of interest-- an issue for every psychiatrist..  166:274. 2009
  • Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients..  165:1594-1603. 2008
  • Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study..  165:1136-1147. 2008
  • Relationship of cognition and psychopathology to functional impairment in schizophrenia..  165:978-987. 2008
  • Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression..  165:863-871. 2008
  • Cost-effectiveness of treatments for adolescent depression: results from TADS..  165:588-596. 2008
  • A Reanalysis of Arrest Rates..  143:675a-6675. 1986
  • Psychotherapy in the Third Reich: Goering Institute by Geoffrey Cocks,